Fenebrutinib significantly reduced new lesions with active inflammation in people with relapsing MS in a Phase 2 trial.

Gov. Hochul announces the launch of phase two of New York's STAR program, assistant eligible homeowners who have school taxes ...

Scancell has linked iSCIB1+ to a 69% response rate in advanced melanoma, lead | Scancell has linked iSCIB1+ to a 69% response ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the ...

CALGARY, AB / ACCESS Newswire / July 22, 2025 / Primary Hydrogen Corp. (TSXV:HDRO)(FRA:83W0)(OTCQB:HNATF) ("Primary" or the ...

Alkermes’ investigational drug helped people with a type of narcolepsy stay awake during the day in a mid-stage trial.

Pinguecula is a benign, common degeneration of the conjunctiva that appears as a grey-white-yellow mass on the bulbar ...

Phase 2 seat allotment result is expected today at ecet-sche.aptonline.in. Candidates should keep their login details ready ...

President John Dramani Mahama has emphasised the importance of responsive leadership, recounting how his previous ...

According to Audra Miller, community development director for Bryan County, portions of the current subdivision are in Zone X ...